logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
S

Statistics in Biopharmaceutical Research

IF1.3
论文数70
被引数
期刊论文 70
发表时间
delete
Challenges of Modeling Biomarker Effects on Time-to-Event Outcomes生物标志物效应在时间-事件结局建模中的挑战
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-07-03
delete0
PREAI
deleteWang, Tuo; Qu, Yongming
delete分享
delete收藏
Bayesian Three-Parameter EMGE Survival Modeling with Hamiltonian Monte Carlo Methods贝叶斯三参数EMGE生存建模与哈密顿蒙特卡洛方法
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteAkhtar, Md Tanwir
delete分享
delete收藏
Extension and Application of the Partial Continual Reassessment Method to a Phase-IIa Dose-Finding Tuberculosis Trial with a Continuous Endpoint部分持续再评估方法的扩展及其在具有连续终点的IIa期结核病剂量寻找试验中的应用
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
deleteOAAI
deleteSerra, Alessandra; Jaki, Thomas; Mozgunov, Pavel
delete分享
delete收藏
Rejoinder - Statistical Methodology Groups in the Pharmaceutical Industry#回复 - 制药行业中的统计方法学团队
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-30
delete0
PREAI
deleteDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
delete分享
delete收藏
Editor's Note编者按
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-30
delete0
PREAI
deleteHe, Weili
delete分享
delete收藏
Commentary on "Statistical Methodology Groups in the Pharmaceutical Industry"对“制药行业的统计方法学小组”的评论
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-21
delete0
PREAI
deleteWang, Li; Yu, Binbing; Mo, May; Roychoudhury, Satrajit; Yu, Ron; Wang, Chenguang; Takeda, Kentaro
delete分享
delete收藏
Commentary on the Manuscript "Statistical Methodology Groups in the Pharmaceutical Industry," by Davenport et al对Davenport等人论文《制药行业中的统计方法学组》的评述
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-19
delete0
PREAI
deletePinheiro (retired), Jose
delete分享
delete收藏
Commentary on "Statistical Methodology Groups in the Pharmaceutical Industry"对“制药行业的统计方法学小组”的评论
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-11
delete1
PREAI
deleteSnapinn, Steven
delete分享
delete收藏
Statistical Methodology Groups in the Pharmaceutical Industry#制药行业中的统计方法学团队
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-09
delete1
PREAI
deleteDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
delete分享
delete收藏
6 Choose 4: A Framework to Understand and Facilitate Discussion of Strategies for Overall Survival Safety Monitoring6选4：理解和促进总体生存安全监测策略讨论的框架
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete1
PREAI
deleteYung, Godwin; Rufibach, Kaspar; Wolbers, Marcel; Yan, Mark; Wang, Jue
delete分享
delete收藏
Information Borrowing in Bayesian Clinical Trials: choice of Tuning Parameters for the Robust Mixture Prior贝叶斯临床试验中的信息借用：稳健混合先验调谐参数的选择
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWeru, Vivienn; Kopp-Schneider, Annette; Wiesenfarth, Manuel; Weber, Sebastian; Calderazzo, Silvia
delete分享
delete收藏
Estimating Treatment Efficacy Controlling for Subsequent Therapy Usage: Comparison of Multiple Methods and Application to Hematologic Oncology Trials控制后续疗法使用以评估治疗效果：多种方法比较及其在血液肿瘤学试验中的应用
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteZheng, Cheng; Mishra-Kalyani, Pallavi; Norsworthy, Kelly J.; Sridhara, Rajeshwari; Logan, Brent R.
delete分享
delete收藏
Statistical Efficiency of Model-Robust Direct Regression Adjustment in Randomized Clinical Trials with Binary Outcomes模型鲁棒直接回归调整在具有二分类结局的随机临床试验中的统计效率
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHagiwara, Yasuhiro; Matsuyama, Yutaka
delete分享
delete收藏
A Meta-Analysis Based Hierarchical Variance Model for Powering One and Two-Sample t-Tests基于元分析的分层方差模型用于单样本和双样本t检验
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteBarth, Jackson; Li, Ren-Cang; Wang, Xinlei
delete分享
delete收藏
Bayesian Estimation of Dynamic Treatment Regimens in a Partially Randomized Patient Preference, Sequential, Multiple-Assignment, Randomized Trial部分随机化患者偏好、序贯、多重分配随机试验中动态治疗方案的贝叶斯估计
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWank, Marianthie; Tamura, Roy N.; Braun, Thomas M.; Kidwell, Kelley M.
delete分享
delete收藏
Multiplicity Control in Clinical Trials with Adaptive Selection Followed by Group-Sequential Testing适应性选择后序贯试验的临床试验多重性控制
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHua, Kaiyuan; Wang, Xiaofei; Luo, Xiaodong
delete分享
delete收藏
Inverse Probability of Treatment Weighting: A Simple and Effective Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials治疗逆概率加权：一种用于随机临床试验中生存终点的协变量调整的简单有效方法
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShao, Yongwu; Zhang, Zhiwei; Ye, Zhishen
delete分享
delete收藏
Mainstream Meta-Analysis of Clinical Trials Produces Strongly Inconsistent Estimators主流临床试验元分析产生强不一致的估计量
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShuster, Jonathan J.
delete分享
delete收藏
Phase 2 Design Considerations from a Program Perspective从项目角度出发的第二阶段设计考虑
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteMielke, Tobias; Ohrn, Fredrik; Dragalin, Vladimir
delete分享
delete收藏
A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab Priors基于校准尖峰-平板先验的贝叶斯自适应标记分层设计用于II期临床试验
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShan, Mu; Lu, Mengyi; Han, Leng; Han, Yan; Zang, Yong
delete分享
delete收藏